{"id":137380,"date":"2026-01-15T18:00:16","date_gmt":"2026-01-15T18:00:16","guid":{"rendered":"https:\/\/www.europesays.com\/se\/137380\/"},"modified":"2026-01-15T18:00:16","modified_gmt":"2026-01-15T18:00:16","slug":"hog-forsaljning-gor-att-sobi-lamnar-omvand-vinstvarning-for-2025","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/137380\/","title":{"rendered":"H\u00f6g f\u00f6rs\u00e4ljning g\u00f6r att Sobi l\u00e4mnar omv\u00e4nd vinstvarning f\u00f6r 2025"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">S\u00e5v\u00e4l int\u00e4kter som den justerade ebita-marginalen v\u00e4ntas bli h\u00f6gre \u00e4n tidigare guidning. I samband med att nyheten kablades ut tog aktien ett tydligt skutt upp\u00e5t. Dock f\u00f6ll kursen tillbaka n\u00e4stan lika fort och noteras nu ned runt 2 procent.<\/p>\n<p>Sobi redovisar hel\u00e5rsint\u00e4kter p\u00e5 cirka 28 miljarder kronor, motsvarande en tillv\u00e4xt p\u00e5 omkring 15 procent vid fasta v\u00e4xelkurser (CER), drivet av h\u00f6gre \u00e4n v\u00e4ntad f\u00f6rs\u00e4ljning under fj\u00e4rde kvartalet f\u00f6r Doptelet, Gamifant och hemofiliportf\u00f6ljen.<\/p>\n<p>Den justerade ebita-marginalen uppgick till cirka 40 procent av int\u00e4kterna, en \u00f6kning j\u00e4mf\u00f6rt med tidigare, till f\u00f6ljd av de starkare int\u00e4kterna.<\/p>\n<p>Vid rapporten f\u00f6r tredje kvartalet i oktober 2025 hade bolaget r\u00e4knat med en int\u00e4ktstillv\u00e4xt p\u00e5 ett l\u00e5gt tv\u00e5siffrigt procenttal vid CER och en justerad ebita-marginal i den mellersta till \u00f6vre delen av 30-procentspannet.<\/p>\n<p>Sobi l\u00e4mnar fullst\u00e4ndig rapport den 5 februari.<br class=\"col-start-2\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"S\u00e5v\u00e4l int\u00e4kter som den justerade ebita-marginalen v\u00e4ntas bli h\u00f6gre \u00e4n tidigare guidning. I samband med att nyheten kablades&hellip;\n","protected":false},"author":2,"featured_media":107138,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[72,70,71,34,31,33,32,30,11925],"class_list":{"0":"post-137380","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ekonomi","8":"tag-business","9":"tag-economy","10":"tag-ekonomi","11":"tag-se","12":"tag-svenska","13":"tag-sverige","14":"tag-sweden","15":"tag-swedish","16":"tag-swedish-orphan-biovitrum"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115900424036969999","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/137380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=137380"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/137380\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/107138"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=137380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=137380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=137380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}